HERON THERAPEUTICS, INC. /DE/ (HRTX) Operating Lease, Payments USD 2019 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Heron Therapeutics, Inc. /De/ annual/quarterly Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Heron Therapeutics, Inc. /De/ Operating Lease, Payments for the quarter ending September 30, 2020 was $1 M, a 25% increase year-over-year.
  • Heron Therapeutics, Inc. /De/ Operating Lease, Payments for the twelve months ending September 30, 2020 was $3.3 M.
  • Heron Therapeutics, Inc. /De/ annual Operating Lease, Payments for 2023 was $3 M, a 3.45% increase from 2022.
  • Heron Therapeutics, Inc. /De/ annual Operating Lease, Payments for 2022 was $2.9 M.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3 M +$100 K +3.45% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-12
2022 $2.9 M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-12
2019 $3.4 M Jan 1, 2019 Dec 31, 2019 10-K 2020-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.